Member Article

New US Contract Win for Crawford Healthcare

Advanced wound care company Crawford Healthcare has announced a significant new contract for its US business, Crawford Healthcare Inc., receiving an Innovative Technology contract for its Touchless Care Zinc Protectant Spray from Vizient, Inc., the largest member driven healthcare performance improvement company in the United States.

The contract was based on a recommendation of Touchless Care by hospital experts in this category who serve on one of Vizient’s member-led councils. Vizient reserves its Innovative Technology contracts for technologies that demonstrate an ability to enhance clinical care or patient safety, and those that improve an organisation’s care delivery and business model.

Touchless Care Zinc Oxide Protectant Spray is a unique product designed to treat incontinence associated dermatitis, commonly referred to as nappy rash. Its formula of 25% Micro-fine Zinc and 20% Dimethicone, coupled with its differentiated application process, helps clinicians and patients by improving clinical outcomes, reducing pain, saving time, supplies and waste. The Micro-fine zinc and Dimethicone mixture allows for better coverage with a breathable, translucent protective barrier that seeps into the cracks and crevasses of the epidermis. The spray-on application allows clinicians to apply the product to sensitive, private and irritated areas without touching the patient. This provides the patient a greater sense of dignity and less pain, while reducing the potential for spreading bacteria through cross contamination.

“Crawford Healthcare is excited about the opportunity to work with the Vizient membership and to offer enhanced savings on a product that helps treat a condition that patients and clinicians don’t always want to talk about. This product’s ability to increase patient dignity, reduce pain and help a nurse improve outcomes is a prime example of why we are passionate about our company, our jobs and our products. This innovative technology contract demonstrates Crawford’s ability to bring unique and outcomes driven products to the U.S. market,” says Dave Posten, V.P. Sales and U.S. Commercialization.

Richard Anderson, Crawford CEO, added: “This is another success for our U.S. business and testament to our world class products and people. We look forward to a long and successful relationship with Vizient.”

“Due to the number of products and services being released and marketed as ‘innovative’, member hospitals truly value the thorough review process in place at Vizient to help them identify products worth further evaluation at their own facilities,” said Debbie Archer, director of procurement and leader of Vizient’s Innovative Technology programme for suppliers. “After a full review of Touchless Care Zinc Protectant Spray, Vizient’s member council agreed this solution offers unique and incremental benefit over other products available on the market today, and recommended it for an Innovative Technology contract. We are pleased to award this new contract to Crawford Healthcare.”

Since 2003, nearly 2,200 new and innovative products and technologies have been submitted through the Vizient Innovative Technology program. Vizient works with member-led councils and task forces to identify and review potentially innovative products. If it is determined that a product is innovative, a contract may be awarded outside of Vizient’s competitive bid cycle.

As the fastest growing advanced woundcare company in the UK, now battling on a world stage against the industry heavyweights, this latest agreement furthers Crawford position in increasing its international share of a global wound care market expected to reach $22billion (USD) by 2022.

This was posted in Bdaily's Members' News section by Jean Needles .